专利内容由知识产权出版社提供
专利名称：T CELL ACTIVATION INHIBITOR,
PHARMACEUTICAL COMPOSITIONCONTAINING SAME, AND SCREENINGMETHOD FOR T CELL ACTIVATIONINHIBITING SUBSTANCE
发明人：YAMASHITA, TOSHIHIDE,KUBO, TAKEKAZU申请号：EP10835979申请日：20101208公开号：EP2510948A4公开日：20130501
摘要： An inhibitor of a molecule of repulsive (RGMA) orientation as the activeingredient for use in the prophylaxis or treatment of an autoimmune disease, such as cellautoimmune disease, rheumatism, multiple sclerosis, autoimmune diseases of the nervoussystem, such as syndrome Gui- Llain-Barré, neuro-Behcet's disease, malignant anemia,type I diabetes, systemic lupus erythematosus (SLE), inflammatory bowel diseases (IBD),Sjogren's syndrome, atopic dermatitis, Goodpasture's syndrome, Grave's disease,hemolytic anemia , autoimmune thrombocytopenic purpura, glomerulonephritis,myasthenia gravis, Hashimoto's disease.
申请人：MITSUBISHI TANABE PHARMA CORPORATION
更多信息请下载全文后查看
